Hyderabad-based Hetero Healthcare Ltd’s Covifor, the generic version of Covid-19 drug Remdesivir, reached here on Monday, an official of the Health Department said. The drug would be used for critical patients undergoing treatment at Covid Hospitals in the State, he added.
The drug is available in 100 mg vials (injectable). It needs to be administered intravenously in a hospital, critical care setting under the supervision of a registered medical practitioner, the company said in a statement.
The maximum retail price has been fixed at Rs 5,400 per vial for the drug.
Pharma major Cipla has also said it would price its generic version of Remdesivir at less than Rs 5,000 per vial.
Besides, Odisha would also receive its first consignment of Covid-19 drug FabiFlu (favipiravir) manufactured by the Glenmark Pharmaceuticals Limited. Around 1,200 strips of the drug would be sent to different hospitals in the State.
